By Federico Cappuzzo, MD Posted: February 12, 2020 Lung cancer treatment is becoming extremely complex. It requires specific competencies to identify the correct diagnosis, tumor biology, staging, and best therapeutic […] Read more
PROVIDER RESOURCES
MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC
INDUSTRY SUPPORTED
COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events